Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Work In Process (2010 - 2026)

Charles River Laboratories International (CRL) posted Work In Process of $195.7 million for Q2 2026, little changed on a QoQ basis from $195.6 million in Q1 2026, and down 9.09% year-over-year from $215.2 million in Q2 2025.

Analysis

Charles River Laboratories International (CRL) Work In Process (2010 - 2026) Analysis & Trends

Charles River Laboratories International has reported Work In Process for 17 years, with the latest figure at $195.7 million in Q2 2026.

  • On a quarterly basis, Work In Process fell 9.09% year-over-year to $195.7 million in Q2 2026; TTM through Jun 2026 was $195.7 million, a 9.09% decrease from a year earlier, with the FY2025 full-year figure at $201.0 million, down 5.19% from the prior year.
  • Work In Process was $195.7 million for Q2 2026 at Charles River Laboratories International, roughly flat from $195.6 million in the prior quarter.
  • The five-year high for Work In Process was $228.5 million in Q3 2023, with the low at $177.3 million in Q1 2022.
  • Average Work In Process over 5 years is $210.0 million, with a median of $213.6 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2026: Work In Process grew 27.02% in 2022, then fell 9.41% in 2026.
  • Over 5 years, Work In Process stood at $204.0 million in 2022, then rose by 11.76% to $228.0 million in 2023, then slipped by 7.02% to $212.0 million in 2024, then declined by 5.19% to $201.0 million in 2025, then fell by 2.66% to $195.7 million in 2026.
  • The last three Work In Process figures came in at $195.7 million (Q2 2026), $195.6 million (Q1 2026), and $201.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 195.66 Mn
Mar 28, 2026 195.62 Mn
Dec 27, 2025 201.00 Mn
Sep 27, 2025 210.88 Mn
Jun 28, 2025 215.23 Mn
Mar 29, 2025 215.95 Mn
Dec 28, 2024 212.00 Mn
Sep 28, 2024 220.32 Mn
Jun 29, 2024 218.89 Mn
Mar 30, 2024 221.79 Mn
Dec 30, 2023 228.00 Mn
Sep 30, 2023 228.52 Mn
Jul 1, 2023 227.68 Mn
Apr 1, 2023 217.30 Mn
Dec 31, 2022 204.00 Mn
Sep 24, 2022 199.98 Mn
Jun 25, 2022 190.81 Mn
Mar 26, 2022 177.26 Mn
Dec 25, 2021 160.61 Mn
Sep 25, 2021 176.00 Mn